Stocks and Investing
Stocks and Investing
Wed, July 28, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, July 27, 2021
[ 12:00 AM ] - WOPRAI
Sumant Kulkarni Maintained (BIIB) at Strong Buy with Increased Target to $423 on, Jul 27th, 2021
Sumant Kulkarni of Canaccord Genuity, Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $359 to $423 on, Jul 27th, 2021.
Sumant has made no other calls on BIIB in the last 4 months.
There are 16 other peers that have a rating on BIIB. Out of the 16 peers that are also analyzing BIIB, 6 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $341 on, Friday, July 23rd, 2021
- Terence Flynn of "Goldman Sachs" Maintained at Hold with Increased Target to $436 on, Monday, June 14th, 2021
- Mohit Bansal of "Citigroup" Upgraded from Strong Sell to Hold and Increased Target to $440 on, Tuesday, June 8th, 2021
- Brian Skorney of "Baird" Upgraded from Sell to Hold and Increased Target to $382 on, Tuesday, June 8th, 2021
- Carter Gould of "Barclays" Maintained at Hold with Increased Target to $395 on, Tuesday, June 8th, 2021
- Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $245 on, Monday, April 12th, 2021
These are the ratings of the 10 analyists that currently disagree with Sumant
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $455 on, Friday, July 23rd, 2021
- Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $450 on, Friday, June 18th, 2021
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $647 on, Monday, June 14th, 2021
- Aaron Gal of "Bernstein" Upgraded from Hold to Buy and Held Target at $500 on, Friday, June 11th, 2021
- Colin Bristow of "UBS" Upgraded from Hold to Strong Buy and Held Target at $463 on, Thursday, June 10th, 2021
- Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $475 on, Thursday, June 10th, 2021
- Matt Phipps of "William Blair" Upgraded from Hold to Buy on, Tuesday, June 8th, 2021
- Michael Yee of "Jefferies" Maintained at Strong Buy with Increased Target to $500 on, Tuesday, June 8th, 2021
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $452 on, Tuesday, June 8th, 2021
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $325 on, Tuesday, May 18th, 2021
Contributing Sources